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Abstract 
A synthetic approach to the C3–C15 segment of the cytotoxic marine metabolite phorboxazoles is described. 
This segment consists of a methylene linked bisoxane structure. The first pyran ring was constructed by a Lewis 
acid catalyzed diene–aldehyde cyclocondensation. The β-C-glucoside substitution pattern of this ring was 
established by a stereoselective allylation. Ozonolysis of vinyl group and enantioselective allylation of the 
racemic aldehyde generated two separable homoallylic alcohols (−)-22 and (+)-23. The Mosher's esters of each 
alcohol were determined to be >90% de. Reaction of (−)-22 with acryloyl chloride, followed by ring closing 
metathesis gave the dihydro-2-pyrone target (−)-5. Mitsunobu inversion of (+)-23 with p-nitrobenzoic 
acid, hydrolysis, and esterification with acryloyl chloride and ring closing metathesis gave pseudoenantiomeric 
segment (+)-6. 
A synthetic approach to the C3–C15 segment of the cytotoxic marine metabolite phorboxazoles is described. 
The C5–C9 pyran ring was constructed by a Lewis acid catalyzed diene–aldehyde cyclocondensation, while the 




Phorboxazoles, C3–C15 bisoxane segment, stereoisomers, phorboxazoles 
The phorboxazoles A and B (1a and b) are isomeric macrolides isolated from the marine sponge Phorbas sp.1a In 
addition to exhibiting antifungal activity against Candida albicans, both phorboxazoles inhibit the growth of 
most of the 60 tumor cell lines in the NCI panel at concentrations <8×10−10 M. This level of activity places 
phorboxazole among the most potent cytostatic agents known. While the exact mechanism of action is 
unknown, the phorboxazoles do not interfere with tubulin polymerization/depolymerization as is the case for 
many other antitumor agents (e.g. epothiolone, taxol). Initial results indicate that 1a arrests Burkitt lymphoma 
CA46 cells in the S phase.1c 
The complex structure of 1 consists of four oxane rings, two oxazole rings, 15 asymmetric centers, and a 
conjugated diene segment. The complete structure was assigned on the basis of NMR spectral studies, Mosher 
ester data, degradation, and model synthesis.1 The outstanding biological activity of 1a/b, combined with their 
complex structural architecture, has led to significant activity by a number of research groups,2 and three total 
syntheses.3 The three syntheses are all convergent, with the initial preparation of fragments roughly 
encompassing the C3–C15 bisoxane portion, the C20–C27 oxane ring, and the C31–C46 diene–oxane fragment. 
Our retrosynthetic strategy disconnects the target into three major fragments, 2–4 (Scheme 1), with 
connections similar to those reported by Forsyth3a and by Evans.3b–d We herein report our detailed study on the 
enantioselective synthesis of a C3–C15 segment (−)-5, its pseudoenantiomer (+)-6, and the diastereomer (+)-






1. Results and discussion 
Lewis acid catalyzed diene–aldehyde cyclocondensation5 of 8 with 1-methoxy-3-trimethylsilyloxy-1,3-butadiene 
(9) in the presence of BF3·Et2O, followed by brief treatment with CF3CO2H gave dihydropyrone rac-10 (Eq. 
(1), Table 1). In a similar fashion, cyclocondensation in the presence of ZnCl2, or TiCl4, or MgBr2 gave the same 
product. Asymmetric cyclocondensation6a of 8 with the chiral auxiliary modified diene 1-l-menthyloxy-3-tert-
butyldimethylsilyloxy-1,3-butadiene (11)6b in the presence of (+)-Eu(hfc)3 (hexane), followed by elimination of 
methanol gave (5S)-10 in good yield. Unfortunately, comparison of the optical rotation of this product with the 
literature value2e indicated that it was only 10% ee. Cyclocondensation of 8 with 9 in the presence of the 
Keck's R-BINOL/Ti(iPrO)4/CF3CO2H catalyst7 likewise gave (5S)-10 with good enantioselectivity (>90% ee) albeit in 
low isolated yield (19%). Unfortunately in our hands, attempts to optimize the yield of this reaction were 
unsuccessful.(1) 
Table 1. Lewis acid catalyzed diene–aldehyde cyclocondensation 
Lewis acid/rxn conditions Yield (%) 
BF3·Et2O/Et2O/−78°C to rt/9 h 71 
ZnCl2/Et2O/−78°C/9 h, 23°C/12 h 70 
TiCl4/Et2O/78°C/9 h, 23°C/12 h 50 
MgBr2/Et2O/78°C/9 h, 23°C/12 h 31 
(+)-Eu(hfc)3/hexane/rt/24 ha 52 (5S, 10% ee) 
Ti(iPrO)4/R-BINOL/CF3CO2H/Et2O 19 (5S, 95% ee) 
a1-(1-l-Menthyloxy)-3-(tert-butyldimethylsilyloxy)-1,3-butadiene (11) was used instead of 9. 
Reaction of rac-10 with mercuric acetate in methanol, followed by treatment with NaBH3CN gave the methyl 
glycoside 12 (Scheme 2). Compound 12 was assigned the β-stereochemistry on the basis of the 1H NMR signal 
for the anomeric proton (δ 4.54, dd, J=2.7, 9.0 Hz). The larger coupling constant is consistent with an axial–axial 
orientation of the anomeric proton with one on the adjacent carbon. Reduction of 12 with LiAlH(OtBu)3 gave the 
equatorial alcohol 13, while reduction of 12 with l-selectride gave a mixture of 13 and the axial 
alcohol 14 (Scheme 2). The structural assignments for 13 and 14 are based on their 1H NMR spectral data. In 
particular, the signals for H9 and H7 (phorboxazole numbering) of 13 (δ 4.26, dd, J=1.9, 9.5 Hz and δ 3.60, br m, 
1/2W=26 Hz) are consistent with atetrahydropyran bearing all equatorial substituents, while these signals 
for 14 (δ 4.69, dd, J=2.1, 9.9 Hz and δ 4.31, pentet, J=3.0 Hz) are consistent with a C7 axial hydroxyl group. The 





Acylation of 13 gave 15 (Scheme 3). Treatment of 15 with allyl trimethylsilane/BF3·Et2O gave a separable mixture 
of 16 and 17 (Scheme 3). The 1H NMR spectrum of 17 is conspicuous in its absence of a signal for the acetate 
group and by the presence of signals for 5 olefinic protons. In contrast, the 1H NMR spectrum of 16 contains 
signals at δ 5.77 (tdd, 1H) and 5.07–4.80 (m, 3H) corresponding to the vinyl group and the C7 proton, and a 
singlet at δ 2.04 (3H) corresponding to the acetate methyl. The trans- stereochemistry of the allyl substituent in 
both 16 and 17 was assigned on the basis of the expected9 axial attack of nucleophiles on the cyclic oxonium ion 
generated from 15. The formation of 17 presumably arises from elimination of methanol from 15 to generate 
the pseudoglycal 18. A carbon-Ferrier rearrangement of 18 would give the product 17. Changing the Lewis acid 




Ozonolysis of 16, followed by treatment of the ozonide with triphenylphosphine, gave the aldehyde rac-
19 (Scheme 4). Cyclocondensation of 19 with 9 in the presence of TiCl4 gave an inseparable mixture of 
dihydropyrones 20, which are diastereomeric at C11. The structural assignment for 20 is based on its 1H NMR 
spectral data. In particular, the signals corresponding to the C15 proton of the two diastereomers appear 
at δ 7.20 (d) and 7.17 (d), while the signals corresponding to the C14 proton appear at δ 5.36 (d) and 5.35 
(d) ppm. Integration of the C15 signals indicated that the diastereomers were formed in a 2:1 ratio. 
Cyclocondensation of 19 with 9 in the presence of ZnCl2 or BF3·Et2O in place of TiCl4 gave a similar 2:1 mixture of 





Pyranyl aldehydes similar to 19 are known to undergo cyclocondensation with 9 with modest 
diastereoselectivity (4:1–5:1).11 In these cases, the major diastereomer possesses the 9S∗,11R∗ relative 
stereochemistry. One rationalization for this stereoselectivity is approach of the silyloxydiene 9 to the less 
hindered face of a chelated structure (c.f. 21). It should be noted that the 9S∗,11R∗ relative stereochemistry is 
opposite to that desired for the phorboxazoles. 
Due to the lack of any significant diastereoselectivity in the cyclocondensation of 19, it was decided to introduce 
the C11–C15 pyran ring via sequential allylation–esterification-ring-closing metathesis.12 Toward this end, 
reaction of rac-19 with B-allyldiisopinocampheylborane (prepared from (−)-(IPC)2BOMe) under salt-free 
conditions,13 followed by oxidative work up with NaBO3, gave a separable mixture of the diastereomers (−)-
22 and (+)-23 (41 and 42%, respectively, Eq. (2)). The relative stereochemistry of 22 and 23 were assigned by 
comparison of their 13C NMR spectral data with that of the diastereomeric compounds 24 and 25 (Fig. 2), 
previously reported by Hoffmann's group.2m In particular, the spectrum of 22 contains signals at δ 70.6, 69.7, 
and 67.2 ppm (C5, C9, C11, phorboxazole numbering, specific assignments not intented) while the spectrum 




In comparison, the spectrum of 24 contains signals at δ 71.2, 69.5, and 67.6 ppm, while the spectrum 
of 25 contains signals at δ 67.8, 67.0, and 66.3 ppm. 
Analysis of the 1H NMR spectra (CDCl3) of the (R)- and (S)-MTPA esters of 22 indicated separation of the H-13 
signals; integration of these signals indicated that the Mosher's esters were >90% de. The absolute configuration 
of 22 at C11 (S) is based on the relative chemical shifts for H-13 signals of the (R)- and (S)-MTPA esters; this 
signal for the (R) ester appears downfield of that for the (S) ester.14 In a similar fashion, integration of the H-13 
signals of the (R)- and (S)-MTPA esters of 23 indicated each to be >90% de. The absolute configuration of 23 at 
C11 (S) is based on the relative chemical shifts of these signals; the signal for the (R) ester appears downfield of 
that for the (S) ester.14 
Reaction of the diastereomeric alcohols (−)-22 or (+)-23 with acryloyl chloride gave the diastereomeric 
unsaturated esters (−)-26 or (+)-27 (Scheme 5).15 The structures of acrylate esters 26 and 27 were assigned on 
the basis of their NMR spectral data. In particular, doublet of doublets signals present at ca. δ 6.37, 6.09, and 
5.79 ppm in their 1H NMR spectra and resonances at ca. δ 165.5, 130.5, and 128.7 ppm in their 13C NMR spectra 
are characteristic of the acrylate group. Ring closing metathesis16 of (−)-26 or (+)-27 in the presence of Grubbs' 
catalyst gave the dihydropyran-2-ones (−)-5 or (+)-7, respectively.17 The structures of 5 and 7 were assigned on 
the basis of their NMR spectral data. In particular, signals present at ca. δ 6.7–6.8 (ddd) and 6.0–5.9 (dd) ppm in 
their 1H NMR spectra and at ca. δ 144.9 and 121.4 ppm in their 13C NMR spectra are characteristic of the olefin 




The enantiomers of certain naturally occurring substances fortuitously exhibit interesting biological activity.18 It 
was envisioned that inversion of the C11 stereocenter present in (+)-23 would generate a molecule 
enantiomeric with (−)-22. To this end, reaction of 2° alcohol (+)-23 with p-nitrobenzoic acid in the presence of 
DEAD/PPh3 proceeded with inversion19 to give (+)-28 (Scheme 6). Hydrolysis of both the p-nitrobenzoate and 
acetate esters of (+)-28 gave diol (+)-29. In a similar fashion, hydrolysis of (−)-22 gave the enantiomeric diol (−)-
29. The 1H and 13C NMR spectra of (+)-29 and (−)-29 were identical. Reaction of (+)-29 with 2 equiv. of acryloyl 
chloride gave the bis-acrylate ester (+)-30. Ring closing metathesis of the bis-acrylate (+)-30 proceeded only via 
formation of the six-membered dihydropyran-2-one ring to give (+)-6. 
 
Scheme 6. Reagents (a) p-NO2PhCO2H, DEAD, PPh3 (51%); (b) K2CO3, MeOH (72–88%); (c) H2CCHCOCl, NEt3, 
DMAP (43%); (d) Ru(CHPh)(PCy3)2Cl2 (0.07 equiv.), Ti(iPrO)4, CH2Cl2 (79%). 
 
In summary, the C3–C15 segment of the phorboxazoles (in the form of optically active dihydropyran-2-one (−)-5) 
was prepared in 9 steps from the known aldehyde 8 via the alcohol (−)-22. The presence of the α,β-unsaturated 
lactone should allow for introduction of the requisite C13 hydroxyl substituent12b and the C15–C16 bond in a 
stereoselective fashion. Additionally, the enantiomeric segment (+)-6 was prepared from (+)-23. 
2. Experimental 
2.1. General data 
Spectrograde solvents were used without purification with the exception of dry ether and dry THF which were 
distilled from sodium benzophenone ketyl and dichloromethane which was distilled from P2O5 and then stored 
over molecular seives. Anhydrous hexane and anhydrous toluene were purchased from Aldrich. Column 
chromatography was performed on silica gel 60 (60–200 mesh, Aldrich). Melting points were obtained on a Mel-
Temp melting point apparatus and are uncorrected. All 1H and 13C NMR spectra were recorded at 300 and 
75 MHz, respectively. Elemental analyses were obtained from Midwest Microlabs, Indianapolis, IN and high 
resolution mass spectra were obtained from the Washington University Resource for Biomedical and Bioorganic 
Mass Spectrometry. 
2.1.1. Dihydropyrone (10) 
To a solution of 3-(tert-butyldi-phenylsilyloxy)propanal20 (8, 11.42 g, 36.5 mmol) in ether (75 mL) cooled to 
−78°C was added dropwise 1-methoxy-3-trimethylsilyloxy-1,3-butadiene (9, 10.0 g, 5.80 mmol) in ether (25 mL). 
After stirring for 5 min, BF3·Et2O (7 mL, 56.9 mmol) was added dropwise over a 5 min period. The mixture was 
stirred for 9 h during which it was slowly warmed to rt. Saturated aqueous NaHCO3 was added, the reaction was 
stirred for 30 min, and then extracted with ether (3×75 mL). The combined organic layers were dried (MgSO4) 
and the solvent evaporated to afford a reddish brown oil. This residue was dissolved in CH2Cl2 (100 mL), 
trifluoroacetic acid (7 drops) was added, and the mixture stirred for 18 h at rt. Saturated aqueous NaHCO3 was 
added, the mixture stirred for 30 min, the layers separated, and the aqueous layer extracted with 
CH2Cl2 (4×75 mL). The combined organic layers were dried (MgSO4) and the solvent evaporated. The residue was 
purified by chromatography (hexane–ethyl acetate=9:1) to give 10 as a colorless oil (9.879 g, 71%); 1H NMR 
(CDCl3) δ 7.66–7.63 (m, 4H), 7.47–7.37 (m, 6H), 7.29 (d, J=6.0 Hz, 1H), 5.40 (d, J=6.2 Hz, 1H), 4.67 (tdd, J=4.4, 8.6, 
12.7 Hz, 1H), 3.90–3.74 (m, 2H), 2.59–2.42 (m, 2H), 2.08–1.97 (m, 1H), 1.93–1.83 (m, 1H), 1.04 (s, 9H); 13C NMR 
(CDCl3) δ 192.8, 163.3, 135.7, 133.6, 130.0, 127.9, 107.3, 76.6, 59.3, 42.2, 37.4, 27.0, 19.4; FAB-
HRMS m/z 387.1980 (calcd for C23H28O3SiLi [M+Li]+ m/z 387.1968). 
Effect of Lewis acid: ZnCl2. The reaction of aldehyde 8 with diene 9 in the presence of ZnCl2 (1.0 M in ether, 
1 equiv.) was carried out in ether at −78°C for 9 h, followed by 12 h at room temperature. Reaction of the 
residue with trifluoroacetic acid in CH2Cl2 was carried out as previously described. Purification of the crude 
product by chromatography gave 10 as a pale yellow oil (70%). 
Effect of Lewis acid: TiCl4. The reaction of aldehyde 8 with diene 9 in the presence of TiCl4 (1 equiv.) was carried 
out in ether at −78°C for 9 h, followed by 12 h at room temperature. Reaction of the residue with trifluoroacetic 
acid in CH2Cl2 was carried out as previously described. Purification of the crude product by chromatography 
gave 10 as a pale yellow oil (50%). 
Effect of Lewis acid: MgBr2. The reaction of aldehyde 8 with diene 9 in the presence of MgBr2 (1 equiv.) was 
carried out in ether at −78°C for 9 h, followed by 12 h at room temperature. Reaction of the residue with 
trifluoroacetic acid in CH2Cl2 was carried out as previously described. Purification of the crude product by 
chromatography gave 10 as a pale yellow oil (31%). 
Effect of chiral Lewis acid and chiral auxillary modified butadiene. The reaction of aldehyde 8 with 1-(1-l-
menthyloxy)-3-(tert-butyldimethylsilyloxy)-1,3-butadiene6b in the presence of (+)-Eu(hfc)3 (0.05 equiv.) was 
carried out in anhydrous hexane at room temperature. After 24 h, NEt3 (4 mL) and methanol (2 mL) were added 
and the mixture was concentrated under vacuum. Reaction of the residue with trifluoroacetic acid in CH2Cl2 was 
carried out as previously described. Purification of the crude product by chromatography gave 10 as a pale 
yellow oil (52%). The 1H NMR spectrum of this product was identical with that of rac-10: [α]D=−4.1 (c 1.32, CHCl3) 
[lit.2e [α]D=−35.8 (c 1.0, CHCl3) 88%ee]. 
Effect of Lewis acid: BINOL–Ti(iPrO)4. To a solution of (R)-1,1′-binaphthol (75.3 mg, 0.263 mmol) in ether (10 mL) 
was added 4 Å molecular sieves (526 mg). To this suspension was added dropwise, by syringe, 
Ti(iPrO)4 (0.0374 mL, 0.127 mmol). The reaction mixture turned a reddish-brown in color. To the mixture was 
added a solution of CF3CO2H in CH2Cl2 (3 μL, 0.5 M, 0.15 mmol) and the reaction mixture was heated at reflux for 
1 h. After the mixture was cooled to room temperature, a solution of 8 (411 mg, 1.32 mmol) in ether (5 mL) was 
added dropwise. The resultant mixture was cooled to −78 °C and 9 (0.313 mL) was added dropwise. The reaction 
mixture was stirred at −78°C for 30 min, and then stored in the freezer (−5°C) for 48 h. Saturated aqueous 
NaHCO3 (15 mL) was added and the mixture was stirred for 45 min. The mixture was filtered through filter-aid, 
the filter bed was washed with ether (4×25 mL) and the combined organic layers dried (MgSO4) and 
concentrated. Reaction of the residue with trifluoroacetic acid in CH2Cl2 was carried out as previously described. 
Purification of the crude product by chromatography gave 10 as a pale yellow oil (19%). [α]D=−39 (c 0.84, CHCl3) 
[lit.2e [α]D=−35.8 (c 1.0, CHCl3) 88%ee]. 
2.1.2. β-Methyl glycoside (12) 
To a solution of dihydro-pyrone 10 (3.00 g, 7.89 mmol) in dry methanol (25 mL) was added, in one portion, 
Hg(OAc)2 (3.1 g, 9.7 mmol). The reaction mixture was stirred at rt for 6 h, and the solvent was evaporated. The 
residue was dissolved in dry THF (25 mL) and cooled to −78°C. To the cooled solution was added, via syringe, a 
solution of NaBH3CN (0.2181 g, 3.471 mmol) in THF (2 mL). The reaction mixture was stirred for 4 h, diluted with 
pentane and the solvent evaporated. The residue was purified by chromatography (hexane–ethyl acetate=19:1) 
to give 12 as a colorless oil (2.204 g, 69%): Rf 0.49 (hexane–ethyl acetate=4:1); 1H NMR (CDCl3) δ 7.67–7.61 (m, 
4H), 7.46–7.34 (m, 6H), 4.54 (dd, J=2.7, 9.0 Hz, 1H), 3.95–3.85 (m, 2H), 3.79 (td, J=5.1, 10.2 Hz, 1H), 3.46 (s, 3H), 
2.66 (ddd, J=2.6, 3.9, 14.8 Hz, 1H), 2.43 (dd, J=9.7, 14.8 Hz, 1H), 2.38 (br d, J=15.1 Hz, 1H), 4H), 2.28 (dd, J=11.3, 
15.1 Hz, 1H), 1.92–1.84 (m, 2H), 1.04 (s, 9H); 13C NMR (CDCl3) δ 205.9, 135.7, 133.8, 129.9, 127.9, 101.2, 68.2, 
59.7, 56.6, 48.1, 47.1, 38.9, 27.1, 19.4; FAB-HRMS m/z 419.2238 (calcd for C24H32O4SiLi [M+Li]+ m/z 419.2230). 
Anal. calcd for C24H32O4Si: C, 69.86; H, 7.82. Found: C, 69.85; H, 7.79. 
2.1.3. Reduction of 12 with LiAlH(tBuO)3 
To a solution of 12 (1.764 g, 4.275 mmol) in dry THF (20 mL) was added, in small portions over a 15 min period, 
solid LiAlH(OtBu)3 (1.358 g, 5.341 mmol). The reaction mixture was stirred at rt for 3 h, at which time TLC 
analysis indicated complete consumption of 12. Water (10 mL) was cautiously added dropwise, the mixture was 
extracted with ether (4×50 mL) and the combined extracts were dried (MgSO4) and the solvent evaporated. The 
residue was purified by chromatography (hexane–ethyl acetate=4:1) to give 13 as a colorless oil (1.640 g, 
92%): Rf 0.12 (hexane–ethyl acetate=4:1); IR (CHCl3, cm−1) 3440; 1H NMR (CDCl3) δ 7.68–7.63 (m, 4H), 7.46–7.34 
(m, 6H), 4.26 (dd, J=1.9, 9.5 Hz, 1H), 3.92–3.73 (m, 3H), 3.60 (br m, 1/2W=26 Hz, 1H), 3.42 (s, 3H), 2.17 
(tdd, J=1.9, 4.6, 12.0 Hz, 1H), 1.92–1.78 (m, 3H), 1.54 (d, J=5.1 Hz, OH), 1.42–1.33 (m, 2H), 1.05 (s, 9H); 13C NMR 
(CDCl3) δ 135.7, 134.0, 129.8, 127.8, 101.2, 68.6, 67.2, 60.2, 56.5, 41.1, 40.9, 38.6, 27.0, 19.4; FAB-
HRMS m/z 421.2381 (calcd for C24H34O4SiLi [M+Li]+ m/z 421.2386). Anal. calcd for C24H34O4Si: C, 69.52; H, 8.26. 
Found: C, 69.45; H, 8.17. 
2.1.4. Reduction of 12 with l-selectride 
A solution of l-selectride (2 mL, 1.0 M THF, 2.0 mmol) in dry THF (8 mL) was cooled to −78°C. To the cooled 
solution was added dropwise via syringe, over a period of 10 min, a solution of 12 (371 mg, 0.900 mmol) in dry 
THF (5 mL). The reaction mixture was stirred for 3 h, during which time the mixture was allowed to come to 
room temperature and TLC analysis indicated completion. Water (8 mL) was cautiously added dropwise, 
followed by 6N NaOH (0.6 mL), 30% H2O2 (0.6 mL) and aqueous K2CO3 (10 mL). The mixture was extracted with 
ether (3×15 mL) and the combined extracts were dried (MgSO4) and the solvent evaporated. The residue was 
purified by chromatography (hexane–ethyl acetate=4:1) to give a 1:1 mixture of 13 and 14 as a colorless oil 
(267 mg, 72%). The axial alcohol 14 was only characterized as a mixture with 13. 
14: Rf 0.12 (hexane–ethyl acetate=4:1); 1H NMR (CDCl3, partial) δ 7.68–7.63 (m, 4H), 7.46–7.34 (m, 6H), 4.69 
(dd, J=2.1, 9.9 Hz, 1H), 4.31 (pentet, J=3.0 Hz, 1H), 4.22 (dd, J=4.4, 6.3 Hz, 1H), 3.42 (s, 3H), 1.92–1.20 (m, 7H), 
1.05 (s, 9H). 
2.1.5. Acetoxy β-methyl glycoside (15) 
To a solution of 13 (1.90 g, 4.582 mmol) in acetic anhydride (20 mL) was added sodium acetate (0.3758 g, 
4.582 mmol). The reaction mixture was heated at reflux for 30 min, diluted with water and extracted with ether 
(4×20 mL). The combined ethereal extracts were repeatedly washed with saturated NaHCO3, followed by brine, 
dried (MgSO4) and the solvent evaporated. The residue was purified by chromatography (hexane–ethyl 
acetate=9:1) to give 15 as a colorless oil (1.924 g, 92%); IR (CHCl3, cm−1) 1740; 1H NMR (CDCl3) δ 7.69–7.64 (m, 
4H), 7.46–7.34 (m, 6H), 4.93 (tt, J=5.0, 11.5 Hz, 1H), 4.33 (dd, J=1.9, 9.8 Hz, 1H), 3.89 (ddd, J=5.4, 8.1, 10.1 Hz, 
1H), 3.76 (td, J=5.1, 10.2 Hz, 1H), 3.68 (br m, 1/2W=21 Hz, 1H), 3.43 (s, 3H), 2.19 (tdd, J=2.3, 4.8, 11.8 Hz, 1H), 
2.05 (s, 3H), 1.96 (br dd, J=5.0, 12.2 Hz, 1H), 1.87–1.79 (m, 2H), 1.43 (dt, J=9.7, 11.9 Hz, 1H), 1.29 (q, J=12.1 Hz, 
1H), 1.06 (s, 9H); 13C NMR (CDCl3) δ 171.0, 135.7, 134.0, 129.8, 127.8, 101.0, 69.1, 68.4, 60.0, 56.5, 38.6, 37.3, 
37.0, 27.0, 21.4, 19.4; FAB-HRMS m/z 463.2489 (calcd for C26H36O5SiLi [M+Li]+ m/z 463.2492). Anal. calcd for 
C26H36O5Si: C, 68.38; H, 7.95. Found: C, 68.38; H, 7.92. 
2.1.6. Allylation of 15 with TMSOTf 
A solution of 15 (0.2244 g, 0.4913 mmol) in anhydrous CH3CN (5 mL) was cooled to 0°C. To the cooled solution 
was added allyltrimethylsilane (5 mL, 3.6 g, 31 mmol). After stirring for 10 min, trimethylsilyl triflate (0.048 mL, 
0.055 g, 0.246 mmol) was added dropwise via syringe. The reaction mixture was stirred for ca. 15 min, diluted 
with water, and extracted with ether. The combined ether extracts were dried (MgSO4) and the solvent 
evaporated. The residue was purified by chromatography (hexane–ethyl acetate=9:1) to give 16 as a pale yellow 
oil (0.1684 g, 73%): Rf 0.65 (hexane–ethyl acetate=9:1); 1H NMR (CDCl3) δ 7.68–7.64 (m, 4H), 7.46–7.35 (m, 6H), 
5.77 (tdd, J=7.0, 10.3, 17.0 Hz, 1H), 5.07–4.80 (m, 3H), 4.05–3.92 (m, 2H), 3.84–3.67 (m, 3H), 2.46 (td, J=7.2, 
14.4 Hz, 1H), 2.23 (td, J=7.0, 14.2 Hz, 1H), 2.04 (s, 3H), 1.90–1.78 (m, 2H), 1.72–1.62 (m, 2H), 1.38 (td, J=9.3, 
13.0 Hz, 1H), 1.05 (s, 9H); 13C NMR (CDCl3) δ 170.8, 135.8, 134.9, 134.1, 129.8, 127.9, 117.3, 70.9, 67.7, 66.0, 
60.5, 38.5, 37.1, 36.6, 33.9, 27.0, 21.6, 19.4; FAB-HRMS m/z 473.2730 (calcd for C28H38O4SiLi 
[M+Li]+ m/z 473.2699). Anal. calcd for C28H38O4Si: C, 72.05; H, 8.21. Found: C, 71.65; H, 8.07. 
2.1.7. Allylation of 15 with BF3·Et2O 
A solution of 15 (95.4 mg, 0.209 mmol) in dry CH2Cl2 (3 mL) was cooled to 0°C. To the cooled solution was added 
allyltrimethylsilane (0.1 mL, 0.63 mmol). After stirring for 10 min, BF3·Et2O (0.04 mL, 0.4 mmol) was added 
dropwise via syringe. The reaction mixture was stirred for 20 min at 0°C, and then warmed to room temperature 
and stirred for 3 h, diluted with saturated aqueous NaHCO3, and extracted with CH2Cl2 (2×10 mL). The combined 
extracts were dried (MgSO4) and the solvent evaporated. The residue was purified by chromatography (hexane–
ethyl acetate=19:1) to give 17 (30.1 mg, 35%) followed by 16 (25.3 mg, 26%) both as colorless oil. 
17: Rf 0.78 (hexane–ethyl acetate=19:1); 1H NMR (CDCl3) δ 7.72–7.65 (m, 4H), 7.46–7.35 (m, 6H), 5.91–5.77 (m, 
2H), 5.72 (br d, J=10.2 Hz, 1H), 5.10–5.00 (m, 2H), 4.16 (br s, 1H), 3.98 (dddd, J=4.2, 4.2, 8.4, 8.4 Hz, 1H), 3.89–
3.71 (m, 2H), 2.41 (td, J=7.2, 14.1 Hz, 1H), 2.24 (td, J=7.1, 14.1 Hz, 1H), 2.07–1.65 (m, 4H), 1.06 (s, 9H). This 
product was not further characterized. 
2.1.8. Aldehyde (19) 
A solution of 16 (0.5200 g, 1.114 mmol) in dry CH2Cl2 (15 mL) was cooled to −78°C in a dry ice/acetone bath. The 
system was purged with carrier gas (compressed air) for 20 min, and then ozone (generated from the 
compressed air with a Welsbach apparatus) was bubbled through the solution until a blue color persisted (ca. 
15 min). The system was purged with carrier gas until the blue color disappeared. Triphenylphosphine (1.39 g, 
5.31 mmol) was added and the mixture was stirred and allowed to warm to rt over a period of 2.5 h. The 
reaction mixture diluted with brine and stirred for 10 min. The mixture was extracted with CH2Cl2 (2×10 mL) and 
the combined extracts dried (MgSO4), and concentrated. The residue was purified by chromatography (hexane–
acetone, 9:1–4:1 gradient) to give 19 as a colorless oil (0.4632 g, 89%); 1H NMR (CDCl3) δ 9.70 (dd, J=1.7, 2.4 Hz, 
1H), 7.68–7.63 (m, 4H), 7.45–7.35 (m, 6H), 5.07 (br m, 1/2W=26 Hz, 1H), 4.54 (m, 1H), 4.00 (tt, J=4.1, 8.1 Hz, 1H), 
3.81–3.65 (m, 2H), 2.77 (ddd, J=2.5, 8.4, 16.4 Hz, 1H), 2.50 (ddd, J=1.7, 5.5, 16.4 Hz, 1H), 2.04 (s, 3H), 2.01–1.90 
(m, 2H), 1.80–1.64 (m, 3H), 1.45 (td, J=8.3, 14.2 Hz, 1H), 1.04 (s, 9H). Anal. calcd for C27H36O5Si: C, 69.19; H, 7.74. 
Found: C, 69.07; H, 7.79. 
2.1.9. Bis-pyran (20) 
To a solution of aldehyde 19 (0.2101 g, 0.4489 mmol) in ether (10 mL) cooled to −78°C was added dropwise 1-
methoxy-3-trimethylsilyloxy-1,3-butadiene (0.127 g, 0.735 mmol) in ether (5 mL). After stirring for 5 min, a 
solution of ZnCl2 (0.73 μL, 1.0 M in ether, 0.73 mmol) was added. The mixture was stirred for 3 h at −78°C, then 
warmed to room temperature and stirring was continued for 4 h. Saturated aqueous NaHCO3 was added, the 
reaction was stirred for 30 min, and then extracted with ether (3×10 mL). The combined organic layers were 
dried (MgSO4) and the solvent evaporated to afford a reddish brown oil. This residue was dissolved in 
CH2Cl2 (15 mL), trifluoroacetic acid (3 drops) was added, and the mixture stirred for 8 h at rt. Saturated aqueous 
NaHCO3 was added, the mixture stirred for 30 min, the layers separated, and the aqueous layer extracted with 
CH2Cl2 (4×10 mL). The combined organic layers were dried (MgSO4) and the solvent evaporated. The residue was 
purified by chromatography (hexane–ethyl acetate=9:1) to give 20 as a pale orange oil (0.1092 mg, 45%). 
Analysis by 1H NMR spectroscopy indicated that this is a mixture of diastereomers at C11 (ca. 2:1); 1H NMR 
(CDCl3) δ 7.65–7.60 (m, 4H), 7.46–7.33 (m, 6H), 7.20 (d, J=6.1 Hz, 0.65H) and 7.17 (d, J=5.7 Hz, 0.35H), 5.36 
(d, J=6.1 Hz) and 5.35 (d, J=6.2 Hz, total 1H), 5.08 (m, 1H), 4.53 (m, 1H), 4.26 (m, 1H), 3.99 (m, 1H), 3.81–3.62 (m, 
2H), 2.53–2.32 (m, 2H), 2.05 (s, 3H), 2.01–1.92 (m, 2H), 1.84–1.64 (m, 3H), 1.45 (td, J=8.3, 13.1 Hz, 1H), 1.02 (s, 
9H); EI-HRMS m/z 479.1887 (calcd for C27H31O6Si [M−tBu]+ m/z 479.1890). 
2.1.10. Chiral allylation of 19 
To a solution of (−)-β-methoxydiisopinocampheylborane (4.00 g, 12.6 mmol) in anhydrous toluene (30 mL) at 
−78°C was added via syringe a solution of allylmagnesium bromide (12.4 mL, 1.0 M in ether, 12.4 mmol). The 
reaction mixture was stirred at −78°C for 15 min and then warmed to room temperature over 1.5 h. A white 
precipitate of magnesium salts formed during this time. The reaction mixture was transferred, via syringe, into 
four equal portions in four centrifuge tubes. After centrifugation, the salt-free solution was transferred into a 
second flask containing a solution of 19 (2.26 g, 4.81 mmol) and 4 Å molecular sieves in anhydrous toluene 
(10 mL) at −78°C. The reaction mixture was stirred at −78°C for 6 h, and then slowly warmed to room 
temperature overnight. Proton NMR monitoring indicated disappearance of the starting aldehyde. Solid sodium 
perborate (3.4 g) and water (5 mL) were added and the resultant mixture was heated at reflux for 1 h. After 
cooling to room temperature, brine was added and the reaction mixture stirred for 20 min. The mixture was 
filtered through filter-aid and the filter bed washed with ether (3×100 mL). The combined organic phases were 
dried (MgSO4) and concentrated. The residue was purified by column chromatography (hexane–ethyl 
acetate=19:1) to give 22 (1.044 g, 42%) followed by 23 (1.009 g, 41%) both as colorless oils. 
(−)-22: Rf 0.60 (hexane–ethyl acetate=1:1); [α]D=−6.9 (c 0.94, CHCl3); IR (neat) 3483, 3068, 1736, 1639, 989, 
912 cm−1; 1H NMR (CDCl3) δ 7.65–7.60 (m, 4H), 7.46–7.33 (m, 6H), 5.82 (tdd, J=7.1, 10.8, 16.5 Hz, 1H), 5.15–5.05 
(m, 3H), 4.21–4.07 (m, 2H), 3.84–3.67 (m, 3H), 3.16 (OH), 2.23 (t, J=6.4 Hz, 2H), 2.03 and 2.06–1.94 (s and m, 
5H), 1.88–1.65 (m, 4H), 1.52 (td, J=3.3, 14.2 Hz, 1H), 1.48 (td, J=7.7, 13.2 Hz, 1H), 1.06 (s, 9H); 13C NMR 
(CDCl3) δ 170.2, 135.5, 134.7, 133.8, 129.6, 127.6, 117.4, 70.6, 69.7, 67.2, 66.9, 60.4, 41.7, 38.9, 37.5, 35.2, 35.1, 
26.8, 21.2, 19.1. Anal. calcd for C30H42O5Si: C, 70.55; H, 8.29. Found: C, 70.51; H, 8.34. 
(+)-23: Rf 0.55 (hexane–ethyl acetate=1:1); [α]D=+21.9 (c 1.00, CHCl3); IR (neat) 3457, 3068, 1736, 1644, 994, 
917 cm−1; 1H NMR (CDCl3) δ 7.65–7.60 (m, 4H), 7.46–7.33 (m, 6H), 5.73 (tdd, J=7.3, 9.9, 17.4 Hz, 1H), 5.13–5.02 
(m, 3H), 4.27 (m, 1H), 3.98 (tt, J=4.2, 8.4 Hz, 1H), 3.86–3.77 (m, 2H), 3.70 (m, 1H), 2.27–2.10 (m, 2H), 2.04 (s, 3H), 
2.00–1.85 (m, 3H), 1.77–1.64 (m, 3H), 1.47–1.35 (m, 2H), 1.04 (s, 9H), OH not observed; 13C NMR (CDCl3) δ 170.3, 
135.5, 134.5, 133.8, 129.6, 127.6, 117.9, 67.6, 67.0, 66.8, 66.1, 60.4, 42.3, 38.8, 37.9, 35.8, 34.9, 26.8, 21.1, 19.1. 
Anal. calcd for C30H42O5Si: C, 70.55; H, 8.29. Found: C, 70.25; H, 8.35. 
2.1.11. (R)-MTPA ester of 22 
To a solution of (−)-22 (52.9 mg, 0.104 mmol) in CH2Cl2 (8 mL) was added (R)-α-methoxy(trifluoromethyl)phenyl 
acetic acid (73.0 mg, 0.310 mmol), DMAP (5.0 mg, 0.04 mmol) and DCC (0.35 mL, 0.35 mmol). The reaction 
mixture was stirred for 3 h, and then washed with 3% aqueous HCl, followed by brine, dried (MgSO4) and 
concentrated. The residue was purified by column chromatography (hexane–ethyl acetate=19:1) to give a 
colorless oil (45.4 mg, 60%). Analysis by 1H NMR spectroscopy indicated that the product was >90% de: Rf 0.55 
(hexane–ethyl acetate=7:3); 1H NMR (CDCl3) δ 7.68–7.63 (m, 4H), 7.53–7.50 (m, 2H), 7.41–7.34 (m, 9H), 5.76–
5.62 (m, 1H), 5.18–4.99 (m, 4H), 4.01–3.90 (m, 2H), 3.82–3.66 (m, 3H), 3.51 (s, 3H), 2.46–2.39 (m, 2H), 2.03 and 
2.12–1.80 (s and m, 5H), 1.76–1.62 (m, 4H), 1.37 (td, J=9.0, 13.1 Hz, 1H), 1.03 (s, 9H); 13C NMR (CDCl3) δ 170.3, 
166.0, 135.5, 133.9, 133.8, 132.9, 132.2, 129.6, 128.3, 127.6, 127.4, 118.6, 73.9, 67.2, 66.7, 66.4, 60.4, 55.4, 
38.1, 37.5, 36.0, 35.4, 34.1, 26.9, 26.8, 21.3, 21.2, 19.1. This product was not further characterized. 
2.1.12. (S)-MTPA ester of 22 
The preparation of the (S)-MTPA ester of (−)-22 was carried out in the same fashion as the preparation of the 
(R)-MPTA ester (93%). Analysis by 1H NMR spectroscopy indicated that the product was >90% de: Rf 0.55 
(hexane–ethyl acetate=7:3); 1H NMR (CDCl3) δ 7.68–7.63 (m, 4H), 7.52–7.49 (m, 2H), 7.41–7.33 (m, 9H), 5.62–
5.48 (m, 1H), 5.18–4.94 (m, 4H), 4.10–3.92 (m, 2H), 3.84–3.68 (m, 2H), 3.51 (s, 3H), 2.45–2.27 (m, 2H), 2.10 (m, 
1H), 2.03 and 2.03–1.82 (s and m, 5H), 1.78–1.55 (m, 4H), 1.45–1.32 (m, 1H), 1.04 (s, 9H); 13C NMR 
(CDCl3) δ 170.5, 165.9, 135.5, 133.9, 133.8, 132.9, 132.5, 132.2, 129.6, 128.3, 127.6, 127.4, 118.6, 73.8, 67.2, 
66.8, 66.5, 60.5, 55.4, 38.0, 37.4, 35.9, 34.2, 26.9, 26.8, 21.2, 19.2. This product was not further characterized. 
2.1.13. (R)-MTPA ester of 23 
The preparation of the (R)-MTPA ester of (+)-23 was carried out in the same fashion as the preparation of the 
(R)-MPTA ester (−)-22 (47%). Analysis by 1H NMR spectroscopy indicated that the product was >90% de: Rf 0.35 
(hexane–ethyl acetate=4:1); 1H NMR (CDCl3) δ 7.68–7.63 (m, 4H), 7.52–7.50 (m, 2H), 7.41–7.34 (m, 9H), 5.71 
(tdd, J=7.1, 10.0, 17.0 Hz, 1H), 5.35–5.22 (m, 1H), 5.10–4.95 (m, 3H), 3.93–3.76 (m, 3H), 3.71 (td, J=5.3, 10.6 Hz, 
1H), 3.54 (s, 3H), 2.42 (m, 2H), 2.01 and 2.06–1.75 (s and m, 5H), 1.88–1.65 (m, 4H), 1.45–1.20 (m, 2H), 1.06 (s, 
9H). This product was not further characterized. 
2.1.14. (S)-MTPA ester of 23 
The preparation of the (S)-MTPA ester of (+)-23 was carried out in the same fashion as the preparation of the 
(R)-MPTA ester of (−)-22 (57%). Analysis by 1H NMR spectroscopy indicated that the product was >90% 
de: Rf 0.29 (hexane–ethyl acetate=4:1); 1H NMR (CDCl3) δ 7.68–7.63 (m, 4H), 7.52–7.50 (m, 2H), 7.41–7.34 (m, 
9H), 5.60 (tdd, J=7.2, 10.1, 17.4 Hz, 1H), 5.35–5.22 (m, 1H), 5.10–4.95 (m, 3H), 4.08 (qd, J=3.7, 11.3 Hz, 1H), 
3.99–3.80 (m, 2H), 3.71 (m, 1H), 3.58 (s, 3H), 2.50–2.30 (m, 2H), 2.03 and 2.12–1.90 (s and m, 5H), 1.88–1.50 (m, 
6H), 1.07 (s, 9H). This product was not further characterized. 
2.1.15. Acrylate (−)-26 
To a solution of (−)-22 (105 mg, 0.206 mmol) in CH2Cl2 (5 mL) at 0°C was triethylamine (0.09 mL, 0.62 mmol) and 
DMAP (2.5 mg, 0.021 mmol). Acryloyl chloride (0.02 mL, 0.25 mmol) was added via syringe and the solution was 
stirred at 0°C for 20 min, and then warmed to room temperature and stirred for 2 h. The reaction mixture was 
poured into a separatory funnel with saturated aqueous NaHCO3. The layers were separated and the aqueous 
layer was washed with methylene chloride (3×20 mL). The combined organic layers were dried (MgSO4) and 
concentrated. The residue was purified by column chromatography (hexane–ethyl acetate=4:1) to give (−)-26 as 
a colorless oil (60.3 mg, 52%): Rf 0.27 (hexane–ethyl acetate=4:1), [α]D=−4.0 (c 1.26, CHCl3); IR 3073, 3042, 1788, 
1726, 1636, 1619, 998, 989, 939, 919 cm−1; 1H NMR (CDCl3) δ 7.65–7.60 (m, 4H), 7.46–7.33 (m, 6H), 6.38 
(dd, J=1.3, 17.4 Hz, 1H), 6.09 (dd, J=10.1, 17.4 Hz, 1H), 5.79 (dd, J=1.5, 10.1 Hz, 1H), 5.73 (tdd, J=6.9, 11.0, 
16.5 Hz, 1H), 5.10–4.95 (m, 4H), 4.07 (br m, 1H), 3.97 (dddd, J=2.9, 4.9, 7.9, 9.8 Hz, 1H), 3.85–3.67 (m, 2H), 2.37 
(m, 2H), 2.03 (s, 3H), 2.10–1.64 (m, 7H), 1.34 (td, J=9.4, 12.6 Hz, 1H), 1.05 (s, 9H); 13C NMR (CDCl3) δ 170.3, 165.5, 
135.5, 133.7, 133.2, 130.6, 129.5, 128.6, 127.6, 118.1, 70.9, 68.1, 67.3, 66.2, 60.4, 38.3, 38.2, 36.4, 35.7, 34.0, 
26.8, 21.2, 19.1; FAB-HRMS m/z 507.2187 (calcd for C29H35O6Si [M−tBu]+ m/z 507.2203). 
2.1.16. Acrylate (+)-27 
Reaction of acryloyl chloride with (+)-23 was carried out in a fashion similar to the preparation of acrylate ester 
of (−)-22 (52%): Rf 0.53 (hexane–ethyl acetate=7:3), [α]D=+30.2 (c 1.06, CHCl3); IR 3073, 3037, 1739, 1726, 1634, 
1614, 983, 917 cm−1; 1H NMR (CDCl3) δ 7.69–7.64 (m, 4H), 7.43–7.34 (m, 6H), 6.37 (dd, J=1.8, 17.3 Hz, 1H), 6.09 
(dd, J=10.2, 17.3 Hz, 1H), 5.78 (dd, J=1.8, 10.3 Hz, 1H), 5.70 (tdd, J=7.1, 10.4, 17.3 Hz, 1H), 5.14 (m, 1H), 5.08–
4.96 (m, 3H), 4.12–4.04 (m, 1H), 3.95–3.80 (m, 2H), 3.67 (td, J=5.9, 10.0 Hz, 1H), 2.35 (m, 2H), 2.02 and 2.09–
1.90 (s and m, 5H), 1.84–1.55 (m, 5H), 1.33 (td, J=9.7, 12.7 Hz, 1H), 1.04 (s, 9H); 13C NMR (CDCl3) δ 170.4, 165.4, 
135.5, 133.9, 133.1, 130.4, 129.5, 128.7, 127.6, 118.1, 70.5, 67.6, 67.5, 65.6, 60.2, 39.1, 38.3, 36.4, 35.8, 34.9, 
26.8, 21.2, 19.2; FAB-HRMS m/z 571.3072 (calcd for C33H44O6SiLi [M+Li]+ m/z 571.3067). 
2.1.17. Dihydropyran-2-one (−)-5 
To a solution of (−)-26 (57.2 mg, 0.101 mmol) in degassed CH2Cl2 (50 mL) was added, via syringe, 
Ti(iPrO)4 (0.01 mL, 0.03 mmol). The reaction mixture was heated at reflux for 1 h, and then cooled to room 
temperature. A solution of ‘Grubbs' catalyst’ (16.7 mg, 0.020 mmol) in CH2Cl2 (10 mL) was added via cannula 
transfer at room temperature and the reaction mixture was stirred for 20 h. The mixture was filtered through a 
small bed of silica gel and the filter bed washed with ethyl acetate (3×10 mL). The combined organic layers were 
washed with brine, dried (MgSO4) and concentrated. The residue was purified by column chromatography 
(hexane–ethyl acetate=7:3) to give (−)-5 as a colorless oil (39.9 mg, 73%): Rf 0.065 (hexane–ethyl acetate=7:3); 
[α]D=−38 (c 1.0, CHCl3); IR 1731, 704 cm−1; 1H NMR (CDCl3) δ 7.68–7.61 (m, 4H), 7.46–7.32 (m, 6H), 6.77 
(ddd, J=3.3, 5.3, 9.6 Hz, 1H), 5.97 (br d, J=10.1 Hz, 1H), 5.06 (tt, J=4.5, 9.0 Hz, 1H), 4.52 (m, 1H), 4.24 (dq, J=4.6, 
9.1 Hz, 1H), 3.97 (tt, J=4.2, 8.4 Hz, 1H), 3.81–3.63 (m, 2H), 2.36 (m, 2H), 2.28 (ddd, J=5.5, 9.3, 15.3 Hz, 1H), 2.03 
(s, 3H), 1.97 (td, J=3.1, 12.7 Hz, 1H), 1.86–1.62 (m, 5H), 1.39 (td, J=9.2, 12.9 Hz, 1H), 1.02 (s, 9H); 13C NMR 
(CDCl3) δ 170.3, 164.1, 144.9, 135.5, 133.8, 129.6, 127.7, 121.4, 75.0, 67.2, 66.4, 65.9, 60.2, 38.1, 36.8, 36.2, 
34.4, 28.7, 26.8, 21.2, 19.2; FAB-HRMS m/z 479.1882 (calcd for C27H31O6Si [M−tBu]+ m/z 479.1890). 
2.1.18. Dihydropyran-2-one (+)-7 
The reaction of (+)-27 with Grubbs' catalyst (0.97 equiv.) in methylene chloride was carried out in a fashion 
similar to the ring closing metathesis of (−)-26, except that the reaction was run at room temperature for 20 h. 
Work-up and purification as before gave (+)-7 as a colorless oil (89%): Rf 0.14 (hexane–ethyl acetate=7:3); 
[α]D=+7.7 (c 1.16, CHCl3); IR 3067, 1726, 1235 cm−1; 1H NMR (CDCl3) δ 7.64–7.59 (m, 4H), 7.44–7.33 (m, 6H), 6.70 
(ddd, J=3.0, 5.5, 9.6 Hz, 1H), 5.94 (dd, J=2.5, 9.7 Hz, 1H), 5.08 (tt, J=4.3, 8.7 Hz, 1H), 4.57 (m, 1H), 4.34 (m, 1H), 
4.02 (tt, J=4.1, 8.4 Hz, 1H), 3.84 (ddd, J=4.0, 9.5, 9.8 Hz, 1H), 3.68 (td, J=4.9, 10.2 Hz, 1H), 2.31–2.11 (m, 2H), 2.04 
(s, 3H), 2.04–1.62 (m, 7H), 1.44 (td, J=8.2, 13.4 Hz, 1H), 1.02 (s, 9H); 13C NMR (CDCl3) δ 170.4, 164.0, 144.8, 135.4, 
133.9, 133.6, 129.6, 127.6, 121.3, 74.4, 67.3, 65.5, 65.4, 60.0, 38.0, 37.7, 35.8, 35.0, 29.8, 26.8, 21.3, 19.2. This 
product was not further characterized. 
2.1.19. Mitsunobu inversion of (+)-23 
To a stirred slurry of (+)-23 (358 mg, 0.702 mmol), triphenylphosphine (442 mg, 1.68 mmol), and p-nitrobenzoic 
acid (282 mg, 1.68 mmol) in toluene (5 mL) at −30°C was added diethyl azodicarboxylate (0.26 mL, 1.7 mmol). 
The reaction mixture was warmed to rt overnight. Saturated aqueous NaHCO3 was added and the layers were 
separated. The aqueous layer was extracted with ether (4×20 mL) and the combined organic phases were dried 
(MgSO4) and concentrated. Excess DEAD was removed by kugelrohr distillation and the residue was purified by 
column chromatography (hexane–ethyl acetate=7:3), to give (+)-28 (0.286 g, 51%) as a pale yellow oil: Rf 0.77 
(hexane–ethyl acetate=1:1); [α]D=+8.1 (c 0.94, CHCl3); IR 3067, 3048, 1726, 1639, 1608, 1521, 1352, 921 cm−1; 1H 
NMR (CDCl3) δ 8.25 and 8.16 (AA′BB′, J=9.0 Hz, 4H), 7.68–7.63 (m, 4H), 7.42–7.34 (m, 6H), 5.78 (tdd, J=7.1, 10.1, 
17.1 Hz, 1H), 5.24 (tt, J=5.7, 6.7 Hz, 1H), 5.13–5.01 (m, 3H), 4.16–4.08 (m, 1H), 4.02–3.92 (m, 1H), 3.81–3.64 (m, 
2H), 2.57–2.40 (m, 2H), 2.23 (ddd, J=7.1, 8.6, 14.5 Hz, 1H), 2.02 (s, 3H), 1.86–1.64 (m, 5H), 1.43–1.19 (m, 2H), 
1.03 (s, 9H); 13C NMR (CDCl3) δ 170.3, 164.0, 150.4, 135.7, 135.5, 133.7, 132.9, 130.6, 129.5, 127.6, 123.4, 118.5, 
72.7, 68.1, 67.2, 66.2, 60.3, 38.2, 38.0, 36.3, 35.7, 34.2, 26.7, 21.2, 19.1; FAB-HRMS m/z 666.3054 (calcd for 
C37H45O8NSiLi [M+Li]+ m/z 666.3075). 
2.1.20. Hydrolysis of (+)-28 
A solution of (+)-28 (78.5 mg, 0.119 mmol) in saturated methanolic K2CO3 (10 mL) was stirred at rt until TLC 
monitoring indicated complete comsumption of starting material. Aqueous HCl (1% by volume) was added until 
the solution was neutral. The reaction mixture was extracted with ether (4×25 mL), and the combined organic 
layers were dried (MgSO4) and concentrated. The residue was purified by column chromatography (hexane–
ethyl acetate=1:1) to give (+)-29 (40.3 mg, 72%) as a colorless oil: Rf 0.17 (hexane–ethyl acetate=1:1); [α]D=+9.4 
(c 0.73, CHCl3); IR 3396, 1107 cm−1; 1H NMR (CDCl3) δ 7.69–7.64 (m, 4H), 7.45–7.36 (m, 6H), 5.89–5.75 (m, 1H), 
5.13–5.07 (m, 2H), 4.26–4.21 (m, 1H), 4.05–3.97 (m, 2H), 3.85–3.69 (m, 3H), 3.24 (OH), 2.23 (t, J=6.5 Hz, 1H), 
2.00–1.57 (m, 8H), 1.46 (br d, J=14.4 Hz, 1H), 1.35 (td, J=7.9, 13.0 Hz, 1H), 1.05 (s, 9H); 13C NMR (CDCl3) δ 135.5, 
134.8, 133.7, 129.6, 127.6, 117.4, 70.8, 70.4, 67.0, 64.2, 60.4, 41.7, 38.9, 38.7, 38.5, 37.7, 26.8, 19.1. This 
product was used in the next reaction without further characterizaton. 
2.1.21. Hydrolysis of (−)-22 
The hydrolysis of (−)-22 in saturated methanolic K2CO3 was carried out in a fashion similar to the hydrolysis 
of (+)-28 to give (−)-29 (88%): The 1H and 13C NMR spectra of (−)-29 were identical with (+)-29. [α]D=−5.7 (c 0.88, 
CHCl3). 
2.1.22. Bisacrylate (+)-30 
The bisacrylate ester (+)-30 (43%) of (+)-29 was prepared in the same fashion as the acrylate ester of (−)-
22: Rf 0.78 (hexane–ethyl acetate=1:1), [α]D=+15.5 (c 0.976, CHCl3); IR 3068, 1726 cm−1; 1H NMR (CDCl3) δ 7.69–
7.64 (m, 4H), 7.43–7.34 (m, 6H), 6.40 and 6.38 (2×dd, J=1.6, 17.2 Hz, 2H), 6.09 (2×dd, J=10.3, 17.3 Hz, 2H), 5.83 
and 5.79 (2×dd, J=1.6, 10.3 Hz, 1H), 5.74 (m, 1H), 5.17–5.00 (m, 2H), 4.15–4.05 (m, 1H), 4.03–3.95 (m, 1H), 3.85–
3.68 (m, 2H), 2.38 (m, 2H), 2.07 (td, J=7.5, 14.5 Hz, 1H), 2.00 (br d, J=12.9 Hz, 1H), 1.90–1.65 (m, 5H), 1.40 
(td, J=9.5, 12.7 Hz, 1H), 1.04 (s, 9H); 13C NMR (CDCl3) δ 165.6, 165.4, 135.5, 133.8, 133.7, 132.2, 130.7, 130.6, 
129.5, 128.7, 128.6, 127.6, 118.2, 70.9, 68.0, 67.5, 66.2, 60.3, 38.2, 36.3, 35.8, 34.0, 26.8, 19.1. This product was 
used in the next reaction without further characterizaton. 
2.1.23. Dihydropyran-2-one (+)-6 
The reaction of (+)-30 with Grubbs' catalyst (0.07 equiv.) in CH2Cl2 was carried out in a fashion similar to the ring 
closing metathesis of (−)-22, except that the reaction was run at room temperature for 48 h. Work-up and 
purification as before gave (+)-6 as a colorless oil (79%): Rf 0.56 (hexane–ethyl acetate=1:1); [α]D=+45.0 (c 0.732, 
CHCl3); IR 1721 cm-1; 1H NMR (CDCl3) δ 7.66–7.61 (m, 4H), 7.45–7.34 (m, 6H), 6.77 (ddd, J=3.3, 5.1, 9.5 Hz, 1H), 
6.41 (dd, J=1.5, 17.4 Hz, 1H), 6.10 (dd, J=10.7, 17.4 Hz, 1H), 5.98 (td, J=1.9, 9.6 Hz, 1H), 5.85 (dd, J=1.6, 10.4 Hz, 
1H), 5.16 (tt, J=4.8, 8.7 Hz, 1H), 4.53 (m, 1H), 4.25 (dq, J=9.6, 4.9 Hz, 1H), 4.00 (tt, J=4.1, 8.0 Hz, 1H), 3.81–3.64 
(m, 2H), 2.39–2.24 (m, 3H), 2.01 (td, J=3.5, 13.0 Hz, 1H), 1.90–1.69 (m, 5H), 1.45 (td, J=9.0, 12.9 Hz, 1H), 1.03 (s, 
9H); 13C NMR (CDCl3) δ 165.5, 164.2, 144.9, 135.5, 133.7, 133.6, 131.0, 128.5, 127.7, 121.4, 75.0, 67.4, 66.3, 65.8, 
60.1, 38.0, 36.8, 36.0, 34.3, 28.6, 26.8, 19.1; FAB-HRMS m/z 555.2747 (calcd for C32H40O6SiLi 
[M+Li]+ m/z 555.2754). 
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